PCSK9抑制剂Evolocumab和Alirocumab降低血脂和减少心血管事件的有效性和安全性评价

    Efficacy and Safety of Evolocumab and Alirocumab in Reducing Lipids and Cardiovascular Events

    /

    返回文章
    返回